E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more
All-In with Chamath, Jason, Sacks & Friedberg
00:00
Navigating Regulatory Waters
This chapter explores the complexities of regulatory practices in the tech and pharmaceutical industries, with a focus on the implications of bundling strategies and anti-competitive concerns. The discussion highlights the challenges faced by venture capital investors and advocates for targeted regulation that prioritizes competition over blanket prohibitions on mergers and acquisitions.
Transcript
Play full episode
